Page 4 - சான் பிரான்சிஸ்கோ வா மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MDMA-assisted therapy successful in PTSD patients 2 Three sessions of MDMA-assisted talk therapy resulted in significant symptom reductions for 88 percent of patients with severe, chronic post-traumatic stress disorder (PTSD). In the first Phase III trial of any psychedelic-assisted therapy, participants who received MDMA-assisted therapy reported a significant reduction in post-traumatic stress disorder (PTSD) symptoms compared to those who received placebo with therapy. Additionally, more than two thirds of the MDMA recipients, compared to 32 percent of placebo patients, no longer qualified for a PTSD diagnosis after three treatment sessions. The randomised, blinded, Phase III trial, treated 90 patients with severe, chronic PTSD. Participants were randomised to receive three sessions of either 3,4-methylenedioxymethamphetamine (MDMA, 46 patients) or placebo (44 patients) with identical talk therapy. The primary efficacy endpoint was based on the change from baseline in an indep

University of california san franciscoUnited statesSan franciscoJennifer mitchellRick doblinSan francisco va medical centerDrug administrationPublic benefit corporationMultidisciplinary association of psychedelic studiesMultidisciplinary associationPsychedelic studiesBenefit corporationDeputy associate chiefAssociate professorCalifornia san franciscoபல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா சான் பிரான்சிஸ்கோ